# Itron, Inc.: Form 10-Q for the period ended Sep 30, 2020

- Company: [Itron, Inc.](/companies/itri.md) (CIK 780571)
- Form: 10-Q
- Filed: 2020-11-02
- Accepted by EDGAR: Nov 2, 2020, 12:37 ET
- Period: 2020-09-30
- Accession: 0000780571-20-000025
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/780571/000078057120000025/itri-20200930.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/780571/000078057120000025/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2020-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2020-07-01 to 2020-09-30 | $540.2m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months, 2020-01-01 to 2020-09-30 | $1.65bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2020-07-01 to 2020-09-30 | $396.9m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months, 2020-01-01 to 2020-09-30 | $1.19bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2020-07-01 to 2020-09-30 | $143.3m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2020-01-01 to 2020-09-30 | $453.3m | us-gaap:GrossProfit |
| Research and development | 3 months, 2020-07-01 to 2020-09-30 | $46.2m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months, 2020-01-01 to 2020-09-30 | $149.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2020-07-01 to 2020-09-30 | $65.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2020-01-01 to 2020-09-30 | $215.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2020-07-01 to 2020-09-30 | −$24.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2020-01-01 to 2020-09-30 | −$43.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2020-07-01 to 2020-09-30 | $10.8m | us-gaap:InterestExpense |
| Interest expense | 9 months, 2020-01-01 to 2020-09-30 | $33.8m | us-gaap:InterestExpense |
| Income tax | 3 months, 2020-07-01 to 2020-09-30 | −$12.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2020-01-01 to 2020-09-30 | $366.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2020-07-01 to 2020-09-30 | −$25.4m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2020-01-01 to 2020-09-30 | −$79.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2020-07-01 to 2020-09-30 | −$0.63 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2020-01-01 to 2020-09-30 | −$1.98 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2020-07-01 to 2020-09-30 | −$0.63 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2020-01-01 to 2020-09-30 | −$1.98 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2020-07-01 to 2020-09-30 | 40,337,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2020-01-01 to 2020-09-30 | 40,199,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2020-01-01 to 2020-09-30 | $70.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2020-01-01 to 2020-09-30 | $36.3m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 9 months, 2020-01-01 to 2020-09-30 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2020-09-30 | $586.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2020-09-30 | $1.35bn | us-gaap:AssetsCurrent |
| Total assets | at 2020-09-30 | $3.02bn | us-gaap:Assets |
| Current liabilities | at 2020-09-30 | $586.7m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2020-09-30 | $2.22bn | us-gaap:Liabilities |
| Long-term debt | at 2020-09-30 | $1.31bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2020-09-30 | $21.4m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2020-09-30 | $771.9m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 75,237 characters.

The following discussion and analysis should be read in conjunction with the unaudited consolidated financial statements and notes included in this report and with the consolidated financial statements and the notes thereto for the fiscal year ended December 31, 2019 filed with the Securities and Exchange Commission (SEC) in our Annual Report on Form 10-K on February 27, 2020 (2019 Annual Report).

Documents we provide to the SEC are available free of charge under the Investors section of our website at *www.itron.com* as soon as practicable after they are filed with or furnished to the SEC. In addition, these documents are available at the SEC's website (http://*www.sec.gov).*

### Certain Forward-Looking Statements

*This report contains, and our officers and representatives may from time to time make, "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are neither historical factors nor assurances of future performance. These statements are based on our expectations about, among others, revenues, operations, financial performance, earnings, liquidity, earnings per share, cash flows and restructuring activities including headcount reductions and other cost savings initiatives. This document reflects our current strategy, plans and expectations and is based on information currently available as of the date of this Quarterly Report on Form 10-Q. When we use words such as "expect," "intend," "anticipate," "believe," "plan," “goal,” “seek,” "project," "estimate," "future," “strategy,” "objective," "may," “likely,” “should,” "will," "will continue," and similar expressions, including related to future periods, they are intended to identify forward-looking statements. Forward-looking statements rely on a number of assumptions and estimates. Although we believe the estimates and assumptions upon which these forward-looking statements are based are reasonable, any of these estimates or assumptions could prove to be inaccurate and the forward-looking statements based on these estimates and assumptions could be incorrect. Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. Actual results and trends in the future may differ materially from those suggested or implied by the forward-looking statements depending on a variety of factors. Therefore, you should not rely on any of these forward-looking statements. Some of the factors that we believe could affect our results include our ability to execute on our restructuring plan, our ability to achieve estimated cost savings, the rate and timing of customer demand for our products, rescheduling of current customer orders, changes in estimated liabilities for product warranties, adverse impacts of litigation, changes in laws and regulations, our dependence on new product development and intellectual property, future acquisitions, changes in estimates for stock-based and bonus compensation, increasing volatility in foreign exchange rates, international business risks, uncertainties caused by adverse economic conditions, including, without limitation those resulting from extraordinary events or circumstances such as the COVID-19 pandemic and other factors that are more fully described in Item 1A: “Risk Factors” included in our 2019 Annual Report, Part II - Item 1A of this document, and other reports on file with the SEC. We do not undertake any obligation to publicly update or revise any forward-looking statement, whether written or oral.*

*The impact caused by the ongoing COVID-19 pandemic includes uncertainty as to the duration, spread, severity, and any recurrence of the COVID-19 pandemic, the duration and scope of related government orders and restrictions, impact on overall demand, impact on our customers’ businesses and workforce levels, disruptions of our business and operations, including the impact on our employees, limitations on, or closures of, our facilities, or the business and operations of our customers or suppliers. Our estimates and statements regarding the impact of COVID-19 are made in good faith to provide insight to our current and future operating and financial environment and any of these may materially change due to factors outside our control. For more information on risks associated with the COVID-19 pandemic, please see our updated risk in Part II, Item 1A, “Risk Factors” of this document.*

### Overview

We are a technology and service company, which is a leader in the Industrial Internet of Things (IIoT). We offer solutions that enable utilities and municipalities to safely, securely, and reliably operate their critical infrastructure. Our solutions include the deployment of smart networks, software, services, devices, sensors, and data analytics that allow our customers to manage assets, secure revenue, lower operational costs, improve customer service, improve safety, and enable efficient management of valuable resources. Our comprehensive solutions and data analytics address the unique challenges facing the energy, water, and municipality sectors, including increasing demand on resources, non-technical loss, leak detection, environmental and regulatory compliance, and improved operational reliability.

We operate under the Itron brand worldwide and manage and report under three operating segments: Device Solutions, Networked Solutions, and Outcomes. The product and operating definitions of the three segments are as follows:

*Device Solutions –* This segment primarily includes hardware products used for measurement, control, or sensing that do not have communications capability embedded for use with our broader Itron systems, i.e., hardware-based products not part of a complete "end-to-end" solution. Examples from the Device Solutions portfolio include: standard endpoints that are shipped without Itron communications, such as our standard gas meters, electricity IEC meters, and water meters, in addition to our heat and allocation products; communicating meters that are not a part of an Itron solution such as Smart Spec meters; and the implementation and installation of non-communicating devices, such as gas regulators.

*Networked Solutions –* This segment primarily includes a combination of communicating devices (smart meters, modules, endpoints, and sensors), network infrastructure, and associated application software designed and sold as a complete solution for acquiring and transporting robust application-specific data. Networked Solutions combines the majority of the assets from the recently acquired SSNI organization with our legacy Itron networking products and software and the implementation and installation of communicating devices into one operating segment. Examples from the Networked Solutions portfolio include:

communicating measurement, control, or sensing endpoints such as our Itron® and OpenWay® Riva meters, Itron traditional ERT® technology, Intelis smart gas or water meters, 500G gas communication modules, 500W water communication modules; GenX networking products, network modules and interface cards; and specific network control and management software applications. The IIoT solutions supported by this segment include automated meter reading (AMR), advanced metering infrastructure (AMI), smart grid and distribution automation (DA), and smart street lighting and smart city solutions.

*Outcomes –* This segment primarily includes our value-added, enhanced software and services in which we manage, organize, analyze, and interpret data to improve decision making, maximize operational profitability, drive resource efficiency, and deliver results for consumers, utilities, and smart cities. Outcomes places an emphasis on delivering to Itron customers high-value, turn-key, digital experiences by leveraging the footprint of our Device Solutions and Networked Solutions segments. The revenues from these offerings are primarily recurring in nature and would include any direct management of Device Solutions, Networked Solutions, and other products on behalf of our end customers. Examples from the Outcomes portfolio include: our meter data management and analytics offerings; our managed service solutions including network-as-a-service and platform-as-a-service, forecasting software and services; and any consulting-based engagement. Within the Outcomes segment, we also identify new business models, including performance-based contracting, to drive broader portfolio offerings across utilities and cities.

We have three measures of segment performance: revenues, gross profit (margin), and operating income (margin). Intersegment revenues are minimal. Certain operating expenses are allocated to the operating segments based upon internally established allocation methodologies. Interest income, interest expense, other income (expense), the income tax provision (benefit), and certain corporate operating expenses are neither allocated to the segments nor included in the measures of segment performance.

#### Non-GAAP Measures

To supplement our consolidated financial statements, which are prepared in accordance with accounting principles generally accepted in the United States (GAAP), we use certain adjusted or non-GAAP financial measures, including non-GAAP operating expense, non-GAAP operating income, non-GAAP net income, non-GAAP diluted earnings per share (EPS), adjusted EBITDA, adjusted EBITDA margin, constant currency, and free cash flow. We provide these non-GAAP financial measures because we believe they provide greater transparency and represent supplemental information used by management in its financial and operational decision making. We exclude certain costs in our non-GAAP financial measures as we believe the net result is a measure of our core business. We believe these measures facilitate operating performance comparisons from period to period by eliminating potential differences caused by the existence and timing of certain expense items that would not otherwise be apparent on a GAAP basis. Non-GAAP performance measures should be considered in addition to, and not as a substitute for, results prepared in accordance with GAAP. We strongly encourage investors and shareholders to review our financial statements and publicly-filed reports in their entirety and not to rely on any single financial measure. Our non-GAAP financial measures may be different from those reported by other companies.

In our discussions of the operating results below, we sometimes refer to the impact of foreign currency exchange rate fluctuations, which are references to the differences between the foreign currency exchange rates we use to convert operating results from local currencies into U.S. dollars for reporting purposes. We also use the term "constant currency", which represents results adjusted to exclude foreign currency exchange rate impacts. We calculate the constant currency change as the difference between the current period results translated using the current period currency exchange rates and the comparable prior period's results restated using current period currency exchange rates. We believe the reconciliations of changes in constant currency provide useful supplementary information to investors in light of fluctuations in foreign currency exchange rates.

Refer to the *Non-GAAP Measures* section below on pages 43-46 for information about these non-GAAP measures and the detailed reconciliation of items that impacted free cash flow, non-GAAP operating expense, non-GAAP operating income, non-GAAP net income, adjusted EBITDA, and non-GAAP diluted EPS in the presented periods.

### Total Company Highlights

#### Highlights and significant developments for the three months ended September 30, 2020 compared with the three months ended September 30, 2019

- Revenues were $540.2 million compared with $624.5 million in 2019, a decrease of $84.3 million, or 13%
- Gross margin was 26.5%, compared with 31.5% in the same period last year
- Operating expenses increased $10.3 million, or 7%, compared with 2019, including $43.9 million of restructuring expense related to the 2020 Projects
- Net loss attributable to Itron, Inc. was $25.4 million compared with net income of $16.8 million in 2019
- GAAP diluted EPS decreased by $1.05 to a diluted loss per share of $0.63 in 2020
- Non-GAAP net income attributable to Itron, Inc. was $24.6 million compared with $41.4 million in 2019
- Non-GAAP diluted EPS was $0.61, a decrease of $0.43 compared with 2019
- Adjusted EBITDA was $39.7 million compared with $74.5 million in 2019
- Total backlog was $2.8 billion and twelve-month backlog was $1.1 billion at September 30, 2020

#### Highlights and significant developments for the nine months ended September 30, 2020 compared with the nine months ended September 30, 2019

- Revenues were $1.65 billion compared with $1.87 billion in 2019, a decrease of $225.9 million, or 12%
- Gross margin was 27.5% compared with 30.7% in 2019
- Operating expenses increased $25.3 million, or 5%, compared with 2019, including $43.9 million of restructuring expense related to the 2020 Projects and a $57.3 million loss on sale of business
- Net loss attributable to Itron, Inc. was $79.5 million, compared with net income of $34.4 million in 2019
- GAAP diluted EPS decreased by $2.84 to a diluted loss per share of $1.98 as compared with 2019
- Non-GAAP net income attributable to Itron, Inc. was $48.9 million compared with $103.9 million in 2019
- Non-GAAP diluted EPS was $1.21, a decrease of $1.39 compared with 2019
- Adjusted EBITDA was $122.9 million compared with $213.2 million in 2019

#### Outlook for 2020 due to COVID-19

The COVID-19 pandemic has had global economic impacts including disrupting global supply chains and creating market volatility. The extent of the recent pandemic and its ongoing impact on our operations is volatile but is being monitored closely by management. While certain of our European factories were closed during portions of the first half of 2020 due to government actions and local conditions, all were open throughout the third quarter. Any further closures that may be imposed on us could impact our results for the remainder of 2020. We expect that certain of our customers’ projects and deployments may shift into 2021. Incremental costs we have incurred related to COVID-19, such as personal protective equipment, increased cleaning and sanitizing of our facilities, and other such items, have not been material to date. At this time, we have not identified any significant decrease in long-term customer demand for our products and services. For more information on risks associated with the COVID-19 pandemic, please see our updated risk in Part II, Item 1A, "Risk Factors".

The COVID-19 pandemic remains a rapidly evolving situation. Changes in the mix of earnings or losses from our different geographical operations, as well as any future enactment of tax legislation and other factors, may result in more volatile quarterly and annual effective tax rates. The detrimental impacts to financial results may be partially offset by financial assistance from the U.S. and foreign governments, including employer payroll tax credits for wages paid to employees who are unable to work during the COVID-19 outbreak. Other benefits, including options to defer payroll tax payments and additional deductions, has resulted in reduced future cash outlays in the near term.

#### 2020 Restructuring Plan

On September 17, 2020, our Board of Directors approved a restructuring plan (the "2020 Projects"). The 2020 Projects include activities that continue the Company’s efforts to optimize its global supply chain and manufacturing operations, sales and marketing organizations, and other overhead. These projects are scheduled to be substantially complete by the end of 2022. We estimate pre-tax restructuring charges of $55 million to $65 million, of which approximately $35 million to $45 million will result in cash expenditures, and the remainder relates to non-cash charges. Of the total expected costs, $43.9 million was recognized in the third quarter. Once the 2020 Projects are substantially completed, the Company estimates $20 to $25 million of annualized savings.

#### Sale of Business

On June 25, 2020, we closed on the sale of five subsidiaries comprising our manufacturing and sales operations in Latin America to buyers led by Instalación Profesional y Tecnologías del Centro S.A. de C.V., a Mexican company doing business as Accell in Brazil (Accell), through the execution of various definitive stock purchase agreements. The sale of these Latin America-based operations is part of our continued strategy to improve profitability and focus on growing our Networked Solutions and Outcomes businesses in Latin America and throughout the world. We retained the intellectual property rights to our products sold in Latin America. As part of the transaction, we entered into an intellectual property license agreement whereby Accell will pay a royalty on certain products manufactured by Accell using licensed Company intellectual property. In addition, Accell will serve as an exclusive distributor for our Device Solutions, Networked Solutions, and Outcomes products and services offerings in Latin America. We recognized a loss on sale of business of $57.3 million during the nine months ended September 30, 2020, primarily due to foreign currency translation losses and allocated goodwill. Refer to Item 1: "Financial Statements (Unaudited), Note 17: Sale of Business" for more information.

#### Credit Facility

In March 2020, we drew $400 million U.S. dollars under the revolving line of credit within the 2018 credit facility. In light of the current uncertain environment, we deemed it prudent to increase our cash position and preserve future financial flexibility. The Total Net Leverage Ratio, as defined in the amended 2018 credit facility agreement, was unchanged by this drawing.

### Total Company GAAP and Non-GAAP Highlights and Unit Shipments:

*In thousands, except margin and per share data*

| GAAP Revenues | Three Months Ended September 30, 2020 | 2019 | % Change | Nine Months Ended September 30, 2020 | 2019 | % Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Product revenues | $470,658 | $552,897 | (15)% | $1,437,780 | $1,663,794 | (14)% |
| Service revenues | 69,526 | 71,577 | (3)% | 210,413 | 210,293 | —% |
| Total revenues | 540,184 | 624,474 | (13)% | 1,648,193 | 1,874,087 | (12)% |
| Gross profit | $143,251 | $196,404 | (27)% | $453,334 | $574,881 | (21)% |
| Operating expenses | 167,231 | 156,965 | 7% | 496,331 | 471,061 | 5% |
| Operating income (loss) | (23,980) | 39,439 | NM | (42,997) | 103,820 | NM |
| Other income (expense) | (13,063) | (15,110) | (14)% | (35,020) | (44,983) | (22)% |
| Income tax provision | 11,985 | (6,152) | NM | (366) | (20,692) | (98)% |
| Net income (loss) attributable to Itron, Inc. | (25,357) | 16,847 | NM | (79,475) | 34,386 | NM |
| **Non-GAAP(1)** |  |  |  |  |  |  |
| Non-GAAP operating expenses | $113,554 | $130,387 | (13)% | $364,788 | $388,985 | (6)% |
| Non-GAAP operating income | 29,697 | 66,017 | (55)% | 88,546 | 185,896 | (52)% |
| Non-GAAP net income attributable to Itron, Inc. | 24,634 | 41,396 | (40)% | 48,929 | 103,886 | (53)% |
| Adjusted EBITDA | 39,684 | 74,456 | (47)% | 122,858 | 213,180 | (42)% |
| **GAAP Margins and Earnings Per Share** |  |  |  |  |  |  |
| Gross margin |  |  |  |  |  |  |
| Product gross margin | 23.9% | 29.5% |  | 25.4% | 29.3% |  |
| Service gross margin | 44.4% | 46.5% |  | 41.7% | 41.8% |  |
| Total gross margin | 26.5% | 31.5% |  | 27.5% | 30.7% |  |
| Operating margin | (4.4)% | 6.3% |  | (2.6)% | 5.5% |  |
| Net income (loss) per common share - Basic | $(0.63) | $0.43 |  | $(1.98) | $0.87 |  |
| Net income (loss) per common share - Diluted | $(0.63) | $0.42 |  | $(1.98) | $0.86 |  |
| **Non-GAAP Earnings Per Share(1)** |  |  |  |  |  |  |
| Non-GAAP diluted EPS | $0.61 | $1.04 |  | $1.21 | $2.60 |  |

(1) These measures exclude certain expenses that we do not believe are indicative of our core operating results. See pages 43-46 for information about these non-GAAP measures and reconciliations to the most comparable GAAP measures.

#### Endpoints Summary

Our revenue is driven significantly by sales of endpoints. We classify our endpoints into two categories:

- *Standard Endpoints –* an Itron product delivered primarily via our Device Solutions segment. The majority of our standard endpoint devices are used for delivery and metrology in the electricity, water, and gas distribution industries, and have no built-in remote reading communication technology. However, some standard endpoint devices are shipped with non-Itron communications capabilities and are not a part of an Itron solution, such as the Smart Spec meters, and are classified as a standard endpoint.
- *Networked Endpoints –* an Itron product with the capability of one-way communication or two-way communication of data including remote device configuration and upgrade (consisting primarily of our OpenWay® or Gen X technology). This primarily includes Itron devices used in electricity, water, and gas distribution industries. Networked endpoints also include smart communication modules and network interface cards (NICs). NICs are communicating modules that can be sold separately from the device directly to our customers or to third party manufacturers for use in endpoints such as electric, water, and gas meters; streetlights and smart city devices; sensors or another standard device that the end customer would like to connect to our OpenWay or Gen X Networked Solutions. These endpoints are primarily delivered via our Networked Solutions segment.

A summary of our endpoints shipped is as follows:

*Units in thousands*

| Itron Endpoints | Three Months Ended September 30, 2020 | 2019 | Nine Months Ended September 30, 2020 | 2019 |
| --- | ---: | ---: | ---: | ---: |
| Standard endpoints | 3,890 | 5,420 | 12,410 | 16,460 |
| Networked endpoints | 3,860 | 3,940 | 11,950 | 12,180 |
| Total endpoints | 7,750 | 9,360 | 24,360 | 28,640 |

### Results of Operations

### Revenues and Gross Margin

The actual results of and effects of changes in foreign currency exchange rates on revenues and gross profit were as follows:

*In thousands*

| Total Company | Three Months Ended September 30, 2020 | 2019 | Effect of Changes in Foreign Currency Exchange Rates | Constant Currency Change | Total Change |
| --- | ---: | ---: | ---: | ---: | ---: |
| Revenues | $540,184 | $624,474 | $5,539 | $(89,829) | $(84,290) |
| Gross profit | 143,251 | 196,404 | 1,261 | (54,414) | (53,153) |
|  |  |  | **Effect of Changes in Foreign Currency Exchange Rates** | **Constant Currency Change** | **Total Change** |
|  | **Nine Months Ended September 30,** |  |  |  |  |
| In thousands | **2020** | **2019** |  |  |  |
| **Total Company** |  |  |  |  |  |
| Revenues | $1,648,193 | $1,874,087 | $(13,641) | (212,253) | $(225,894) |
| Gross profit | 453,334 | 574,881 | (3,228) | (118,319) | (121,547) |

#### Revenues - Three months ended September 30, 2020 vs. Three months ended September 30, 2019

Total revenues decreased $84.3 million, or 13%, in the current 2020 quarter, compared with the same period in 2019. We have been negatively impacted by COVID-19, which played a significant role in lower year-over-year results. Product revenues decreased by $82.2 million, and service revenues decreased slightly. Device Solutions decreased by $37.2 million; Networked Solution decreased by $49.6 million; and Outcomes increased by $2.5 million when compared with the same period last year. Changes in exchange rates favorably impacted total revenues in the 2020 period by $5.5 million, of which $5.1 million favorably impacted Device Solutions.

#### Revenues - Nine months ended September 30, 2020 vs. Nine months ended September 30, 2019

Total revenues decreased $225.9 million, or 12%, for the first nine months of 2020, compared with the same period in 2019. We have been negatively impacted by COVID-19, which played a significant role in lower year-over-year results. Product revenues decreased by $226.0 million, and service revenues increased slightly. Device Solutions decreased by $145.3 million; Networked Solutions decreased by $76.6 million; and Outcomes decreased by $4.1 million when compared with the same period last year. Changes in exchange rates unfavorably impacted total revenues by $13.6 million, of which $11.6 million unfavorably impacted Device Solutions.

#### Gross Margin - Three months ended September 30, 2020 vs. Three months ended September 30, 2019

Gross margin in the 2020 period was 26.5%, compared with 31.5% in 2019. We were negatively impacted by unfavorable product mix, inventory reserves, and manufacturing inefficiencies caused by COVID-19. Product sales gross margin decreased to 23.9% for the quarter in 2020, compared with 29.5% in 2019. Gross margin on service revenues decreased to 44.4% in 2020, compared with 46.5% in 2019.

#### Gross Margin - Nine months ended September 30, 2020 vs. Nine months ended September 30, 2019

Gross margin for the current year was 27.5%, compared with 30.7% in 2019. Unfavorable product mix and manufacturing inefficiencies caused by COVID-19 negatively impacted our results. Product sales gross margin decreased to 25.4% in the 2020 period, compared with 29.3% in 2019 and gross margin on service revenues decreased to 41.7%, compared with 41.8% in 2019.

Refer to Operating Segment Results section below for further detail on total company revenues and gross margin.

### Operating Expenses

The actual results of and effects of changes in foreign currency exchange rates on operating expenses were as follows:

*In thousands*

| Total Company | Three Months Ended September 30, 2020 | 2019 | Effect of Changes in Foreign Currency Exchange Rates | Constant Currency Change | Total Change |
| --- | ---: | ---: | ---: | ---: | ---: |
| Sales, general and administrative | $64,982 | $83,666 | $1,011 | $(19,695) | $(18,684) |
| Research and development | 46,224 | 50,612 | 239 | (4,627) | (4,388) |
| Amortization of intangible assets | 11,183 | 16,095 | 80 | (4,992) | (4,912) |
| Restructuring | 44,462 | 6,592 | 171 | 37,699 | 37,870 |
| Loss on sale of business | 380 | — | — | 380 | 380 |
| Total Operating expenses | $167,231 | $156,965 | $1,501 | $8,765 | $10,266 |
|  |  |  | **Effect of Changes in Foreign Currency Exchange Rates** | **Constant Currency Change** | **Total Change** |
|  | **Nine Months Ended September 30,** |  |  |  |  |
| In thousands | **2020** | **2019** |  |  |  |
| **Total Company** |  |  |  |  |  |
| Sales, general and administrative | $215,018 | $264,640 | $(1,266) | $(48,356) | $(49,622) |
| Research and development | 148,999 | 150,551 | (104) | (1,448) | (1,552) |
| Amortization of intangible assets | 33,488 | 48,185 | (71) | (14,626) | (14,697) |
| Restructuring | 41,531 | 7,685 | (10) | 33,856 | 33,846 |
| Loss on sale of business | 57,295 | — | — | 57,295 | 57,295 |
| Total Operating expenses | $496,331 | $471,061 | $(1,451) | $26,721 | $25,270 |

Operating expenses increased $10.3 million for the third quarter of 2020 as compared with the same period in 2019. This was primarily the result of $43.9 million in restructuring expenses recognized for the 2020 Projects during the third quarter of 2020. An additional $0.4 million recognized for the loss on sale of business from the Latin America divestiture, which closed in June 2020. The increase was partially offset by decreases of $18.7 million in sales, general and administrative expenses due to lower variable compensation and reduced travel expenses, and $4.9 million in amortization of intangible assets compared with the

2019 period. Acquisition and integration costs, which are classified within sales, general and administrative expenses, decreased by $6.2 million compared with the same period in 2019.

Operating expenses increased $25.3 million for the nine months ended September 30, 2020 as compared with the same period in 2019. This was primarily the result of $43.9 million in restructuring expense recognized for the 2020 Projects during the third quarter of 2020 and a $57.3 million loss on sale of business resulting from the Latin America divestiture during the second quarter of 2020. The increase was partially offset by decreases of $49.6 million in sales, general and administrative expenses due to lower variable compensation and reduced travel expenses, and $14.7 million in amortization of intangible assets. Acquisition and integration costs, which are classified within sales, general and administrative expenses, decreased by $25.3 million compared with the same period in 2019.

### Other Income (Expense)

The following table shows the components of other income (expense):

*In thousands*

|  | Three Months Ended September 30, 2020 | 2019 | % Change 2020 | Nine Months Ended September 30, 2019 |  | % Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest income | $354 | $517 | (32)% | $2,165 | $1,379 | 57% |
| Interest expense | (9,794) | (11,584) | (15)% | (30,742) | (36,213) | (15)% |
| Amortization of prepaid debt fees | (1,016) | (1,284) | (21)% | (3,029) | (3,686) | (18)% |
| Other income (expense), net | (2,607) | (2,759) | (6)% | (3,414) | (6,463) | (47)% |
| Total other income (expense) | $(13,063) | $(15,110) | (14)% | $(35,020) | $(44,983) | (22)% |

Total other income (expense) for the three and nine months ended September 30, 2020 was a net expense of $13.1 million and $35.0 million, compared with net expense of $15.1 million and $45.0 million in the same periods in 2019.

The lower total expense for the three months ended September 30, 2020, as compared with the same period in 2019, was driven primarily by $2.9 million in lower interest expense for the credit facility due to a lower interest rate in 2020.

The decrease in other income (expense) for the nine months ended September 30, 2020, as compared with the same period in 2019, was primarily driven by $7.1 million in lower interest expense for the credit facility due to a lower interest rate in 2020, and lower foreign currency exchange losses resulting from transactions denominated in a currency other than the reporting entity's functional currency.

### Income Tax Provision

For the three and nine months ended September 30, 2020, our income tax expense (benefit) was $(12.0) million and $0.4 million compared with income tax expense of $6.2 million and $20.7 million for the same periods in 2019. Our tax rate for the three and nine months ended September 30, 2020 of 32% and 0%, respectively, differed from the federal statutory rate of 21% primarily due to a significant loss recognized in the second quarter for the divestiture of the majority of our Latin American business activities. Refer to "Note 17: Sale of Business" for additional information on the transaction. This loss was recognized for tax as a discrete item and resulted in no tax benefit. A discrete tax benefit was recorded in the third quarter for $10.1 million related to the release of a valuation allowance on U.S. foreign tax credit deferred tax assets. This release was triggered by the carryforward of tax attributes due to the filing of amended tax returns in the third quarter. Other rate drivers include losses in jurisdictions for which no benefit is recognized because of valuation allowances on deferred tax assets, the forecasted mix of earnings in domestic and international jurisdictions, a benefit related to excess stock-based compensation, and uncertain tax positions. Our tax rate for the three and nine months ended September 30, 2019 of 25% and 35%, respectively, differed from the federal statutory rate of 21% primarily due to losses in jurisdictions for which no benefit is recognized because of valuation allowances on deferred tax assets as well as the forecasted mix of earnings in domestic and international jurisdictions, a benefit related to excess stock-based compensation, and uncertain tax positions.

For additional discussion related to income taxes, see Item 1: "Financial Statements (Unaudited), Note 10: Income Taxes".

### Operating Segment Results

For a description of our operating segments, refer to Item 1: "Financial Statements (Unaudited), Note 15: Segment Information". The following tables and discussion highlight significant changes in trends or components of each operating segment:

*In thousands*

| Segment Revenues | Three Months Ended September 30, 2020 2019 % Change | Nine Months Ended September 30, 2020 2019 % Change |
| --- | ---: | ---: |
| Device Solutions | $176,128 $213,349 (17)% | $507,572 $652,827 (22)% |
| Networked Solutions | 306,659 356,221 (14)% | 971,984 1,048,564 (7)% |
| Outcomes | 57,397 54,904 5% | 168,637 172,696 (2)% |
| Total revenues | $540,184 $624,474 (13)% | $1,648,193 $1,874,087 (12)% |
|  | **Three Months Ended September 30,** | **Nine Months Ended September 30,** |
|  | **2020** **2019** | **2020** **2019** |
| In thousands | **Gross Profit** **Gross Margin** **Gross Profit** **Gross Margin** | **Gross Profit** **Gross Margin** **Gross Profit** **Gross Margin** |
| **Segment Gross Profit and Margin** |  |  |
| Device Solutions | $20,528 11.7% $40,945 19.2% | $64,843 12.8% $122,451 18.8% |
| Networked Solutions | 102,295 33.4% 135,406 38.0% | 332,368 34.2% 388,717 37.1% |
| Outcomes | 20,428 35.6% 20,053 36.5% | 56,123 33.3% 63,713 36.9% |
| Total gross profit and margin | $143,251 26.5% $196,404 31.5% | $453,334 27.5% $574,881 30.7% |
|  | **Three Months Ended September 30,** | **Nine Months Ended September 30,** |
| In thousands | **2020** **2019** **% Change** | **2020** **2019** **% Change** |
| **Segment Operating Expenses** |  |  |
| Device Solutions | $9,511 $13,040 (27)% | $36,748 $40,734 (10)% |
| Networked Solutions | 30,891 29,769 4% | 94,902 89,723 6% |
| Outcomes | 8,384 9,210 (9)% | 26,655 28,093 (5)% |
| Corporate unallocated | 118,445 104,946 13% | 338,026 312,511 8% |
| Total operating expenses | $167,231 $156,965 7% | $496,331 $471,061 5% |
|  | **Three Months Ended September 30,** | **Nine Months Ended September 30,** |
|  | **2020** **2019** | **2020** **2019** |
| In thousands | **Operating Income (Loss)** **Operating Margin** **Operating Income (Loss)** **Operating Margin** | **Operating Income (Loss)** **Operating Margin** **Operating Income (Loss)** **Operating Margin** |
| **Segment Operating Income (Loss) and Operating Margin** |  |  |
| Device Solutions | $11,017 6.3% $27,905 13.1% | $28,095 5.5% $81,717 12.5% |
| Networked Solutions | 71,404 23.3% 105,637 29.7% | 237,466 24.4% 298,994 28.5% |
| Outcomes | 12,044 21.0% 10,843 19.7% | 29,468 17.5% 35,620 20.6% |
| Corporate unallocated | (118,445) (21.9)% (104,946) (16.8)% | (338,026) (20.5)% (312,511) (16.7)% |
| Total operating income (loss) and operating margin | $(23,980) (4.4)% $39,439 6.3% | $(42,997) (2.6)% $103,820 5.5% |

36

### Device Solutions

The effects of changes in foreign currency exchange rates and the constant currency changes in certain Device Solutions segment financial results were as follows:

*In thousands*

| Device Solutions Segment | Three Months Ended September 30, 2020 | 2019 | Effect of Changes in Foreign Currency Exchange Rates | Constant Currency Change | Total Change |
| --- | ---: | ---: | ---: | ---: | ---: |
| Revenues | $176,128 | $213,349 | $5,123 | $(42,344) | $(37,221) |
| Gross profit | 20,528 | 40,945 | 1,064 | (21,481) | (20,417) |
| Operating expenses | 9,511 | 13,040 | 147 | (3,676) | (3,529) |
|  |  |  | **Effect of Changes in Foreign Currency Exchange Rates** | **Constant Currency Change** | **Total Change** |
|  | **Nine Months Ended September 30,** |  |  |  |  |
| In thousands | **2020** | **2019** |  |  |  |
| **Device Solutions Segment** |  |  |  |  |  |
| Revenues | $507,572 | $652,827 | $(11,588) | $(133,667) | $(145,255) |
| Gross profit | 64,843 | 122,451 | (2,402) | (55,206) | (57,608) |
| Operating expenses | 36,748 | 40,734 | (59) | (3,927) | (3,986) |

#### Revenues - Three months ended September 30, 2020 vs. Three months ended September 30, 2019

Revenues decreased $37.2 million, or 17%. Changes in foreign currency exchange rates favorably impacted revenues by $5.1 million. Revenue was negatively impacted by $18.0 million in the Latin America region in part due to the sale of the business in June 2020, as well as lower shipments in all regions due to reduced demand primarily from COVID-19 delays.

#### Revenues - Nine months ended September 30, 2020 vs. Nine months ended September 30, 2019

Revenues decreased $145.3 million, or 22%. Changes in foreign currency exchange rates unfavorably impacted revenues by $11.6 million. We had reduced shipments driven by COVID-19 delays, and revenue decreased $22.0 million in the Latin America region in part due to the sale of the business in June 2020.

#### Gross Margin - Three months ended September 30, 2020 vs. Three months ended September 30, 2019

For the three months ended September 30, 2020, gross margin was 11.7%, compared with 19.2% for the same period in 2019. The 750 basis point reduction over the prior year was primarily due to unfavorable product mix, inventory reserves, and COVID-19 induced operational inefficiencies.

#### Gross Margin - Nine months ended September 30, 2020 vs. Nine months ended September 30, 2019

For the nine months ended September 30, 2020, gross margin was 12.8%, compared with 18.8% for the same period in 2019. The 600 basis point reduction over the prior year was primarily due to $37.5 million of unfavorable product mix, inventory reserves, and COVID-19 induced operating inefficiencies, partially offset by lower warranty expense of $2.0 million.

#### Operating Expenses - Three months ended September 30, 2020 vs. Three months ended September 30, 2019

Operating expenses decreased $3.5 million, or 27%, compared with 2019. The decrease was primarily related to $2.8 million decrease in research and development costs, and a decrease in sales and marketing expenses of $0.9 million.

#### Operating Expenses - Nine months ended September 30, 2020 vs. Nine months ended September 30, 2019

Operating expenses decreased $4.0 million, or 10%, for the first nine months of 2020, compared with the same period in 2019. The decrease was primarily a result of a $3.0 million decrease in research and development cost, and a $0.9 million decrease in sales and marketing expenses.

### Networked Solutions

The effects of changes in foreign currency exchange rates and the constant currency changes in certain Networked Solutions segment financial results were as follows:

*In thousands*

| Networked Solutions Segment | Three Months Ended September 30, 2020 | 2019 | Effect of Changes in Foreign Currency Exchange Rates | Constant Currency Change | Total Change |
| --- | ---: | ---: | ---: | ---: | ---: |
| Revenues | $306,659 | $356,221 | $(48) | $(49,514) | $(49,562) |
| Gross profit | 102,295 | 135,406 | (39) | (33,072) | (33,111) |
| Operating expenses | 30,891 | 29,769 | 37 | 1,085 | 1,122 |
|  |  |  | **Effect of Changes in Foreign Currency Exchange Rates** | **Constant Currency Change** | **Total Change** |
|  | **Nine Months Ended September 30,** |  |  |  |  |
| In thousands | **2020** | **2019** |  |  |  |
| **Networked Solutions Segment** |  |  |  |  |  |
| Revenues | $971,984 | $1,048,564 | $(1,539) | $(75,041) | $(76,580) |
| Gross profit | 332,368 | 388,717 | (576) | (55,773) | (56,349) |
| Operating expenses | 94,902 | 89,723 | (1) | 5,180 | 5,179 |

#### Revenues - Three months ended September 30, 2020 vs. Three months ended September 30, 2019

Revenues decreased $49.6 million, or 14%, in 2020 compared with 2019. The change was primarily due to delayed deployments driven by COVID-19 delays, with lower product revenue of $47.8 million and lower maintenance service revenue of $1.8 million.

#### Revenues - Nine months ended September 30, 2020 vs. Nine months ended September 30, 2019

Revenues decreased $76.6 million, or 7%, for the first nine months of 2020 compared with the same period in 2019. The change was primarily due to delayed deployments driven by COVID-19 delays, with lower product revenue of $79.8 million partially offset by higher maintenance service revenue of $3.2 million.

#### Gross Margin - Three months ended September 30, 2020 vs. Three months ended September 30, 2019

Gross margin was 33.4% for the period ending September 30, 2020, compared with 38.0% in 2019. The 460 basis point decrease was primarily related to unfavorable product mix and COVID-19 related inefficiencies.

#### Gross Margin - Nine months ended September 30, 2020 vs. Nine months ended September 30, 2019

Gross margin was 34.2% for the 2020 period, compared with 37.1% in 2019. The 290 basis point decrease was primarily related to unfavorable product mix and COVID-19 induced operational inefficiencies.

#### Operating Expenses - Three months ended September 30, 2020 vs. Three months ended September 30, 2019

Operating expenses increased $1.1 million, or 4%, for the quarter in 2020, compared with the same period in 2019. The increase was primarily related to higher research and development expenses of $2.6 million, partially offset by a decrease of $1.5 million in sales and marketing expenses.

#### Operating Expenses - Nine months ended September 30, 2020 vs. Nine months ended September 30, 2019

Operating expenses increased $5.2 million, or 6%, for the first nine months of 2020, compared with the same period in 2019. The increase was primarily related to higher research and development expenses of $7.4 million, partially offset by a decrease of $2.3 million in sales and marketing expenses.

### Outcomes

The effects of changes in foreign currency exchange rates and the constant currency changes in certain Outcomes segment financial results were as follows:

*In thousands*

| Outcomes Segment | Three Months Ended September 30, 2020 | 2019 | Effect of Changes in Foreign Currency Exchange Rates | Constant Currency Change | Total Change |
| --- | ---: | ---: | ---: | ---: | ---: |
| Revenues | $57,397 | $54,904 | $466 | $2,027 | $2,493 |
| Gross profit | 20,428 | 20,053 | 234 | 141 | 375 |
| Operating expenses | 8,384 | 9,210 | 25 | (851) | (826) |
|  |  |  | **Effect of Changes in Foreign Currency Exchange Rates** | **Constant Currency Change** | **Total Change** |
|  | **Nine Months Ended September 30,** |  |  |  |  |
| In thousands | **2020** | **2019** |  |  |  |
| **Outcomes Segment** |  |  |  |  |  |
| Revenues | $168,637 | $172,696 | $(513) | $(3,546) | $(4,059) |
| Gross profit | 56,123 | 63,713 | (252) | (7,338) | (7,590) |
| Operating expenses | 26,655 | 28,093 | (8) | (1,430) | (1,438) |

#### Revenues - Three months ended September 30, 2020 vs. Three months ended September 30, 2019

For the 2020 period, revenues increased $2.5 million, or 5%, compared with the 2019 period. This increase was driven by an increase in software license sales and professional services.

#### Revenues - Nine months ended September 30, 2020 vs. Nine months ended September 30, 2019

Revenues decreased $4.1 million, or 2%, for the first nine months of 2020, compared with 2019. This decline was driven by a decrease in hardware and software license sales and professional services.

#### Gross Margin - Three months ended September 30, 2020 vs. Three months ended September 30, 2019

Gross margin decreased to 35.6% for the third quarter of 2020, compared with 36.5% for the same period last year. The 90 basis point decrease was driven by unfavorable product mix and infrastructure investments.

#### Gross Margin - Nine months ended September 30, 2020 vs. Nine months ended September 30, 2019

Gross margin decreased to 33.3% for the period ending in 2020, compared with 36.9% for last year. The 360 basis point decrease was driven by unfavorable product mix and infrastructure investments.

#### Operating Expenses - Three months ended September 30, 2020 vs. Three months ended September 30, 2019

Operating expenses for the 2020 period decreased $0.8 million, compared with the same period last year, with lower product marketing expenses of $0.2 million and lower research and development expenses of $0.6 million.

#### Operating Expenses - Nine months ended September 30, 2020 vs. Nine months ended September 30, 2019

Operating expenses for the first nine months of 2020 decreased $1.4 million, or 5%, compared with the same period last year. This was primarily related to lower product marketing expenses of $0.7 million and lower research and development expenses of $0.7 million.

### Corporate Unallocated

#### Corporate Unallocated Expenses - Three months ended September 30, 2020 vs. Three months ended September 30, 2019

Operating expenses not directly associated with an operating segment are classified as "Corporate unallocated". These expenses increased $13.5 million, or 13%, for the three months ended September 30, 2020 compared with the same period in 2019. This was primarily the result of a $43.9 million restructuring expenses recognized for the 2020 Projects during the third quarter of 2020. The increase was offset by $18.7 million in reduced sales, general and administrative expenses due to lower employee medical costs and reduced travel expenses and a $4.9 million reduction in amortization of intangible assets. Acquisition and integration costs, which are classified within sales, general and administrative expenses, decreased by $6.2 million compared with the same period in 2019.

#### Corporate Unallocated Expenses - Nine months ended September 30, 2020 vs. Nine months ended September 30, 2019

For the first nine months of 2020, corporate unallocated expenses increased $25.5 million, or 8%, compared with the 2019 period. This was primarily the result of a $57.3 million loss on sale of business due to the Latin America divestiture and a $43.9 million restructuring expense recognized for the Itron 2020 Projects during the nine months ended in 2020. The increase was offset by $49.6 million in reduced sales, general and administrative expenses due to lower employee medical costs and reduced travel expenses, and $14.7 million in lower amortization of intangible assets. Acquisition and integration costs, which are classified within sales, general and administrative expenses, decreased by $25.3 million compared with the same period in 2019.

### Bookings and Backlog of Orders

Bookings for a reported period represent customer contracts and purchase orders received during the period for hardware, software, and services that have met certain conditions, such as regulatory and/or contractual approval. Total backlog represents committed but undelivered products and services for contracts and purchase orders at period-end. Twelve-month backlog represents the portion of total backlog that we estimate will be recognized as revenue over the next 12 months. Backlog is not a complete measure of our future revenues as we also receive significant book-and-ship orders, as well as frame contracts. Bookings and backlog may fluctuate significantly due to the timing of large project awards. In addition, annual or multi-year contracts are subject to rescheduling and cancellation by customers due to the long-term nature of the contracts. Beginning total backlog, plus bookings, minus revenues, will not equal ending total backlog due to miscellaneous contract adjustments, foreign currency fluctuations, and other factors. Total bookings and backlog include certain contracts with termination for convenience clause, which will not agree to the total transaction price allocated to the remaining performance obligations disclosed in Item 1: "Financial Statements (Unaudited), Note 16: Revenues".

*In millions*

| Quarter Ended | Quarterly Bookings | Ending Total Backlog | Ending 12-Month Backlog |
| --- | ---: | ---: | ---: |
| September 30, 2020 | $432 | $2,795 | $1,107 |
| June 30, 2020 | 390 | 2,895 | 1,291 |
| March 31, 2020 | 418 | 3,020 | 1,319 |
| December 31, 2019 | 767 | 3,207 | 1,499 |
| September 30, 2019 | 609 | 3,063 | 1,361 |

### Financial Condition

### Cash Flow Information

*In thousands*

|  | Nine Months Ended September 30, 2020 | 2019 |
| --- | ---: | ---: |
| Cash provided by operating activities | $70,571 | $128,100 |
| Cash used in investing activities | (33,472) | (34,593) |
| Cash provided by (used in) financing activities | 402,590 | (73,592) |
| Effect of exchange rates on cash, cash equivalents, and restricted cash | (3,426) | (543) |
| Increase in cash, cash equivalents, and restricted cash | $436,263 | $19,372 |

Cash, cash equivalents, and restricted cash was $586.2 million at September 30, 2020, compared with $149.9 million at December 31, 2019. The $436.3 million increase in cash, cash equivalents, and restricted cash in the 2020 period was primarily the result of a $400 million draw from our credit facility in March 2020, along with cash flows from operating activities, partially offset by acquisitions of property, plant, and equipment.

#### Operating activities

Cash provided by operating activities during the nine months in 2020 was $70.6 million compared with $128.1 million during the same period in 2019. The decrease was primarily due to net loss, as a result of restructuring and loss on sale of business, partially offset by decreased cash used for working capital.

#### Investing activities

Cash used in investing activities during 2020 was $1.1 million lower than in 2019. This slight decrease in use of cash was primarily related to the net cash outflow for the sale of our Latin America operation, and a decrease of $8.3 million in investment of property, plant, and equipment.

#### Financing activities

Net cash provided by financing activities during the nine months in 2020 was $402.6 million, compared with net cash used of $73.6 million for the same period in 2019. In March 2020, we drew on our revolver in the amount of $400 million to increase our cash position and preserve future financial flexibility. In 2019, we repurchased $25 million in shares of our common stock and had net repayments of debt of $50.3 million.

#### Effect of exchange rates on cash and cash equivalents

The effect of exchange rates on the cash balances of currencies held in foreign denominations at September 30, 2020 was a decrease of $3.4 million, compared with a decrease of $0.5 million for the same period in 2019. Our foreign currency exposure relates to non-U.S. dollar denominated balances in our international subsidiary operations.

#### Free cash flow (Non-GAAP)

To supplement our Consolidated Statements of Cash Flows presented on a GAAP basis, we use the non-GAAP measure of free cash flow to analyze cash flows generated from our operations. The presentation of non-GAAP free cash flow is not meant to be considered in isolation or as an alternative to net income as an indicator of our performance, or as an alternative to cash flows from operating activities as a measure of liquidity. We calculate free cash flows, using amounts from our Consolidated Statements of Cash Flows, as follows:

*In thousands*

|  | Nine Months Ended September 30, 2020 | 2019 |
| --- | ---: | ---: |
| Cash provided by operating activities | $70,571 | $128,100 |
| Acquisitions of property, plant, and equipment | (36,297) | (44,570) |
| Free cash flow | $34,274 | $83,530 |

Free cash flow fluctuated primarily as a result of changes in cash provided by operating activities. See the cash flow discussion of operating activities above.

### Off-balance sheet arrangements

We have no off-balance sheet financing agreements or guarantees as defined by Item 303 of Regulation S-K at September 30, 2020 and December 31, 2019 that we believe could reasonably likely have a current or future effect on our financial condition, results of operations, or cash flows.

### Liquidity and Capital Resources

Our principal sources of liquidity are cash flows from operations, borrowings, and the sale of our common stock. Cash flows may fluctuate and are sensitive to many factors including changes in working capital and the timing and magnitude of capital expenditures and payments of debt. Working capital, which represents current assets less current liabilities, continues to be in a net favorable position.

#### Borrowings

On October 18, 2019 we amended our credit facility that was initially entered on January 5, 2018 (together with the amendment, the "2018 credit facility"). The 2018 credit facility provides for committed credit facilities in the amount of $1.2 billion U.S. dollars. The 2018 credit facility consists of a $650 million U.S. dollar term loan (the term loan) and a multicurrency revolving line of credit (the revolver) with a principal amount of up to $500 million. The revolver also contains a $300 million standby letter of credit sub-facility and a $50 million swingline sub-facility. The October 18, 2019, amendment extended the maturity date to October 18, 2024 and re-amortized the term loan based on the new balance as of the amendment date.

We drew $400 million in U.S. dollars under the revolving line of credit within the 2018 credit facility in March 2020. In light of the current uncertain environment, we deemed it prudent to increase our cash position and preserve future financial flexibility.

The Total Net Leverage Ratio, as defined in the amended 2018 credit facility agreement, continues to be unchanged by this drawing. Subsequent to September 30, 2020, we repaid $100 million on the revolving line of credit.

On October 19, 2020, we completed a second amendment to our 2018 credit facility. This amendment adjusts the maximum total net leverage ratio thresholds for the period beginning with the fourth quarter of 2020 through the fourth quarter of 2021 to allow for increased operational flexibility. The maximum leverage ratio is increased to 4.75:1 for the fourth quarter of 2020 and the first quarter of 2021 and 4.5:1 for the second quarter through the fourth quarter of 2021. An additional level of pricing was added to the existing pricing grid and is effective throughout the remaining term of the 2018 credit facility. Beginning with the fourth quarter of 2020, the commitment fee ranges from 0.15% to 0.30% and drawn amounts are subject to a margin ranging from 1.00% to 2.00%. Going forward, we do not expect any significant increase in interest expense as the result of this amendment.

Amounts repaid on the term loan may not be reborrowed, and amounts borrowed under the revolver may be repaid and reborrowed until the revolver's maturity, at which time all outstanding loans together with all accrued and unpaid interest must be repaid.

In December 2017 and January 2018, we issued a combined $400 million in aggregate principal amount of 5.00% senior notes maturing January 15, 2026 (Senior Notes). The proceeds were used to refinance existing indebtedness related to the acquisition of SSNI, pay related fees and expenses, and for general corporate purposes. Interest on the Senior Notes is payable semi-annually in arrears on January 15 and July 15, commencing on July 15, 2018. The $10 million interest payment due on July 15, 2020 was paid as of June 30, 2020. The Senior Notes are fully and unconditionally guaranteed, jointly and severally, on a senior unsecured basis by each of our subsidiaries that guarantee the 2018 credit facility.

Prior to maturity, we may redeem some or all of the Senior Notes, together with accrued and unpaid interest, if any, plus a "make-whole" premium. On or after January 15, 2021, we may redeem some or all of the Senior Notes at any time at declining redemption prices equal to 102.50% beginning on January 15, 2021, 101.25% beginning on January 15, 2022 and 100.00% beginning on January 15, 2023 and thereafter to the applicable redemption date. In addition, before January 15, 2021, and subject to certain conditions, we may redeem up to 35% of the aggregate principal amount of Senior Notes with the net proceeds of certain equity offerings at 105.00% of the principal amount thereof to the date of redemption; provided that (i) at least 65% of the aggregate principal amount of Senior Notes remains outstanding after such redemption and (ii) the redemption occurs within 60 days of the closing of any such equity offering.

For further description of our borrowings, refer to Item 1: "Financial Statements (Unaudited), Note 6: Debt".

For a description of our letters of credit and performance bonds, and the amounts available for additional borrowings or letters of credit under our lines of credit, including the revolver that is part of our credit facility, refer to Item 1: "Financial Statements (Unaudited), Note 11: Commitments and Contingencies".

#### Silver Spring Networks, Inc. Acquisition

As part of the acquisition of SSNI, we announced an integration plan to obtain approximately $50 million of annualized savings by the end of 2020. For the nine months ended September 30, 2020, we paid out $11.9 million and we have approximately $4 million to $8 million of estimated cash payments remaining on the integration plan, the majority of which is expected to be paid out in the next 12 months.

#### Restructuring

On September 17, 2020, our Board of Directors approved a restructuring plan (the "2020 Projects"). The 2020 Projects include activities that continue our efforts to optimize its global supply chain and manufacturing operations, sales and marketing organizations, and other overhead. These projects are scheduled to be substantially complete by the end of 2022. We estimate pre-tax restructuring charges of $55 million to $65 million. Of the total estimated charge, approximately $35 million to $45 million will result in cash expenditures, and the remainder relates to non-cash charges.

For the nine months ended September 30, 2020, we paid out a net $10.9 million related to the 2018 restructuring projects. As of September 30, 2020, $79.7 million was accrued for restructuring projects, of which $24.6 million is expected to be paid over the next 12 months.

For further details regarding our restructuring activities, refer to Item 1: "Financial Statements (Unaudited), Note 12: Restructuring".

#### Other Liquidity Considerations

We have tax credits and net operating loss carryforwards in various jurisdictions that are available to reduce cash taxes. However, utilization of tax credits and net operating losses are limited in certain jurisdictions. Based on current projections, we expect to pay, net of refunds, approximately $1 million in state taxes and approximately $7 million in local and foreign taxes during 2020. We expect to receive approximately $7 million in U.S. federal tax refunds. For a discussion of our tax provision and unrecognized tax benefits, see Item 1: "Financial Statements (Unaudited), Note 10: Income Taxes".

As of September 30, 2020, we are under examination by certain tax authorities. We believe we have appropriately accrued for the expected outcome of all tax matters and do not currently anticipate that the ultimate resolution of these examinations will have a material adverse effect on our financial condition, future results of operations, or liquidity.

As of September 30, 2020, there was $37.2 million of cash and short-term investments held by certain foreign subsidiaries in which we are permanently reinvested for tax purposes. As a result of recent changes in U.S. tax legislation, any repatriation in the future would not result in U.S. federal income tax. Accordingly, there is no provision for U.S. deferred taxes on this cash. If this cash were repatriated to fund U.S. operations, additional withholding tax costs may be incurred. Tax is only one of the many factors that we consider in the management of global cash. Accordingly, the amount of taxes that we would need to accrue and pay to repatriate foreign cash could vary significantly.

In several of our consolidated international subsidiaries, we have joint venture partners, who are minority shareholders. Although these entities are not wholly-owned by Itron, Inc., we consolidate them because we have a greater than 50% ownership interest and/or because we exercise control over the operations. The noncontrolling interest balance in our Consolidated Balance Sheets represents the proportional share of the equity of the joint venture entities, which is attributable to the minority shareholders. At September 30, 2020, $7.9 million of our consolidated cash balance is held in our joint venture entities. As a result, the minority shareholders of these entities have rights to their proportional share of this cash balance, and there may be limitations on our ability to repatriate cash to the United States from these entities.

#### General Liquidity Overview

Notwithstanding the expected short to mid-term impacts of the COVID-19 pandemic, we expect to grow through a combination of internal new research and development, licensing technology from and to others, distribution agreements, partnering arrangements, and acquisitions of technology or other companies. We expect these activities to be funded with existing cash, cash flow from operations, borrowings, or the sale of our common stock or other securities. We believe existing sources of liquidity will be sufficient to fund our existing operations and obligations for the next 12 months and into the foreseeable future, but offer no assurances. Our liquidity could be affected by the stability of the electricity, gas, and water industries, competitive pressures, our dependence on certain key vendors and components, changes in estimated liabilities for product warranties and/or litigation, duration of the COVID-19 pandemic, future business combinations, capital market fluctuations, international risks, and other factors described under "Risk Factors" within Item 1A of Part I of our 2019 Annual Report, as well as "Quantitative and Qualitative Disclosures About Market Risk" within Item 3 of Part I included in this Quarterly Report on Form 10-Q.

### Contingencies

Refer to Item 1: "Financial Statements (Unaudited), Note 11: Commitments and Contingencies".

### Critical Accounting Estimates and Policies

Our consolidated financial statements and accompanying notes are prepared in accordance with U.S. GAAP. Preparing consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, and expenses. These estimates and assumptions are based on historical experience and on various other assumptions management believes to be reasonable. Actual results could differ from the amounts reported and disclosed herein. Our critical accounting policies that require the use of estimates and assumptions were discussed in detail in the 2019 Annual Report and have not changed materially.

Refer to Item 1: "Financial Statements (Unaudited), Note 1: Summary of Significant Accounting Policies" included in this Quarterly Report on Form 10-Q for further disclosures regarding new accounting pronouncements.

### Non-GAAP Measures

The accompanying schedule contains non-GAAP financial measures. To supplement our consolidated financial statements, which are prepared in accordance with GAAP, we use certain non-GAAP financial measures, including non-GAAP operating expense, non-GAAP operating income, non-GAAP net income, non-GAAP diluted EPS, adjusted EBITDA, free cash flow, and constant currency. The presentation of this financial information is not intended to be considered in isolation or as a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP, and other companies may define such measures differently. For more information on these non-GAAP financial measures, please see the table captioned "Reconciliations of Non-GAAP Financial Measures to the Most Directly Comparable GAAP Financial Measures".

We use these non-GAAP financial measures for financial and operational decision making and/or as a means for determining executive compensation. Management believes that these non-GAAP financial measures provide meaningful supplemental information regarding our performance and ability to service debt by excluding certain expenses that may not be indicative of our recurring core operating results. These non-GAAP financial measures facilitate management's internal comparisons to our historical performance, as well as comparisons to our competitors' operating results. Our executive compensation plans exclude non-cash charges related to amortization of intangibles and certain discrete cash and non-cash charges, such as acquisition and integration related expenses, or restructuring charges. We believe that both management and investors benefit from referring to these non-GAAP financial measures in assessing our performance and when planning, forecasting and analyzing future periods. We believe these non-GAAP financial measures are useful to investors because they provide greater transparency with respect to key metrics used by management in its financial and operational decision making and because they are used by our institutional investors and the analyst community to analyze the health of our business.

*Non-GAAP operating expenses* and *non-GAAP operating income –* We define non-GAAP operating expenses as operating expenses excluding certain expenses related to the amortization of intangible assets, restructuring, loss on sale of business, corporate transition cost, and acquisition and integration. We define non-GAAP operating income as operating income excluding the expenses related to the amortization of intangible assets, restructuring, loss on sale of business, corporate transition cost, and acquisition and integration. Acquisition and integration related expenses include costs, which are incurred to affect and integrate business combinations, such as professional fees, certain employee retention and salaries related to integration, severances, contract terminations, travel costs related to knowledge transfer, system conversion costs, and asset impairment charges. We consider these non-GAAP financial measures to be useful metrics for management and investors because they exclude the effect of expenses that are related to acquisitions and restructuring projects. By excluding these expenses, we believe that it is easier for management and investors to compare our financial results over multiple periods and analyze trends in our operations. For example, in certain periods, expenses related to amortization of intangible assets may decrease, which would improve GAAP operating margins, yet the improvement in GAAP operating margins due to this lower expense is not necessarily reflective of an improvement in our core business. There are some limitations related to the use of non-GAAP operating expenses and non-GAAP operating income versus operating expenses and operating income calculated in accordance with GAAP. We compensate for these limitations by providing specific information about the GAAP amounts excluded from non-GAAP operating expense and non-GAAP operating income and evaluating non-GAAP operating expense and non-GAAP operating income together with GAAP operating expense and operating income.

*Non-GAAP net income* and *non-GAAP diluted EPS –* We define non-GAAP net income as net income attributable to Itron, Inc. excluding the expenses associated with amortization of intangible assets, amortization of debt placement fees, restructuring, loss on sale of business, corporate transition cost, acquisition and integration, and the tax effect of excluding these expenses. We define non-GAAP diluted EPS as non-GAAP net income divided by the weighted average shares, on a diluted basis, outstanding during each period. We consider these financial measures to be useful metrics for management and investors for the same reasons that we use non-GAAP operating income. The same limitations described above regarding our use of non-GAAP operating income apply to our use of non-GAAP net income and non-GAAP diluted EPS. We compensate for these limitations by providing specific information regarding the GAAP amounts excluded from these non-GAAP measures and evaluating non-GAAP net income and non-GAAP diluted EPS together with GAAP net income attributable to Itron, Inc. and GAAP diluted EPS.

For interim periods, beginning the first quarter of 2019, the budgeted annual effective tax rate (AETR) is used, adjusted for any discrete items, as defined in ASC 740 - Income Taxes. The budgeted AETR is determined at the beginning of the fiscal year. The AETR is revised throughout the year based on changes to our full-year forecast. If the revised AETR increases or decreases by 200 basis points or more from the budgeted AETR due to changes in the full-year forecast during the year, the revised AETR is used in place of the budgeted AETR beginning with the quarter the 200 basis point threshold is exceeded and going forward for all subsequent interim quarters in the year. We continue to assess the AETR based on latest forecast throughout the year and use the most recent AETR anytime it increases or decreases by 200 basis points or more from the prior interim period.

*Adjusted EBITDA –* We define adjusted EBITDA as net income (a) minus interest income, (b) plus interest expense, depreciation and amortization of intangible assets, restructuring, loss on sale of business, corporate transition cost, acquisition and integration related expense, and (c) excluding income tax provision or benefit. Management uses adjusted EBITDA as a performance measure for executive compensation. A limitation to using adjusted EBITDA is that it does not represent the total increase or decrease in the cash balance for the period and the measure includes some non-cash items and excludes other non- cash items. Additionally, the items that we exclude in our calculation of adjusted EBITDA may differ from the items that our peer companies exclude when they report their results. We compensate for these limitations by providing a reconciliation of this measure to GAAP net income (loss).

*Free cash flow –* We define free cash flow as net cash provided by operating activities less cash used for acquisitions of property, plant and equipment. We believe free cash flow provides investors with a relevant measure of liquidity and a useful basis for assessing our ability to fund our operations and repay our debt. The same limitations described above regarding our use of adjusted EBITDA apply to our use of free cash flow. We compensate for these limitations by providing specific information regarding the GAAP amounts and reconciling to free cash flow.

*Constant currency –* We refer to the impact of foreign currency exchange rate fluctuations in our discussions of financial results, which references the differences between the foreign currency exchange rates used to translate operating results from the entity's functional currency into U.S. dollars for financial reporting purposes. We also use the term "constant currency", which represents financial results adjusted to exclude changes in foreign currency exchange rates as compared with the rates in the comparable prior year period. We calculate the constant currency change as the difference between the current period results and the comparable prior period's results restated using current period foreign currency exchange rates.

### Reconciliations of Non-GAAP Financial Measures to the Most Directly Comparable GAAP Financial Measures

The tables below reconcile the non-GAAP financial measures of operating expenses, operating income, net income, diluted EPS, adjusted EBITDA, and free cash flow with the most directly comparable GAAP financial measures.

*In thousands, except per share data*

| TOTAL COMPANY RECONCILIATIONS NON-GAAP OPERATING EXPENSES | Three Months Ended September 30, 2020 | 2019 | Nine Months Ended September 30, 2020 | 2019 |
| --- | ---: | ---: | ---: | ---: |
| GAAP operating expenses | $167,231 | $156,965 | $496,331 | $471,061 |
| Amortization of intangible assets | (11,183) | (16,095) | (33,488) | (48,185) |
| Restructuring | (44,462) | (6,592) | (41,531) | (7,685) |
| Loss on sale of business | (380) | — | (57,295) | — |
| Corporate transition cost | — | (57) | 33 | (1,613) |
| Acquisition and integration related expense | 2,348 | (3,834) | 738 | (24,593) |
| Non-GAAP operating expenses | $113,554 | $130,387 | $364,788 | $388,985 |
| **NON-GAAP OPERATING INCOME** |  |  |  |  |
| GAAP operating income (loss) | $(23,980) | $39,439 | $(42,997) | $103,820 |
| Amortization of intangible assets | 11,183 | 16,095 | 33,488 | 48,185 |
| Restructuring | 44,462 | 6,592 | 41,531 | 7,685 |
| Loss on sale of business | 380 | — | 57,295 | — |
| Corporate transition cost | — | 57 | (33) | 1,613 |
| Acquisition and integration related expense | (2,348) | 3,834 | (738) | 24,593 |
| Non-GAAP operating income | $29,697 | $66,017 | $88,546 | $185,896 |
| **NON-GAAP NET INCOME & DILUTED EPS** |  |  |  |  |
| GAAP net income (loss) attributable to Itron, Inc. | $(25,357) | $16,847 | $(79,475) | $34,386 |
| Amortization of intangible assets | 11,183 | 16,095 | 33,488 | 48,185 |
| Amortization of debt placement fees | 972 | 1,240 | 2,898 | 3,555 |
| Restructuring | 44,462 | 6,592 | 41,531 | 7,685 |
| Loss on sale of business | 380 | — | 57,295 | — |
| Corporate transition cost | — | 57 | (33) | 1,613 |
| Acquisition and integration related expense | (2,348) | 3,834 | (738) | 24,593 |
| Income tax effect of non-GAAP adjustments | (4,658) | (3,269) | (6,037) | (16,131) |
| Non-GAAP net income attributable to Itron, Inc. | $24,634 | $41,396 | $48,929 | $103,886 |
| Non-GAAP diluted EPS | $0.61 | $1.04 | $1.21 | $2.60 |
| Non-GAAP weighted average common shares outstanding - Diluted | 40,559 | 39,903 | 40,507 | 39,884 |
| **ADJUSTED EBITDA** |  |  |  |  |
| GAAP net income (loss) attributable to Itron, Inc. | $(25,357) | $16,847 | $(79,475) | $34,386 |
| Interest income | (354) | (517) | (2,165) | (1,379) |
| Interest expense | 10,810 | 12,868 | 33,771 | 39,899 |
| Income tax provision | (11,985) | 6,152 | 366 | 20,692 |
| Depreciation and amortization | 24,076 | 28,623 | 72,306 | 85,691 |
| Restructuring | 44,462 | 6,592 | 41,531 | 7,685 |
| Loss on sale of business | 380 | — | 57,295 | — |
| Corporate transition cost | — | 57 | (33) | 1,613 |
| Acquisition and integration related expense | (2,348) | 3,834 | (738) | 24,593 |
| Adjusted EBITDA | $39,684 | $74,456 | $122,858 | $213,180 |
| **FREE CASH FLOW** |  |  |  |  |
| Net cash provided by operating activities | $44,785 | $50,037 | $70,571 | $128,100 |
| Acquisitions of property, plant, and equipment | (7,248) | (18,059) | (36,297) | (44,570) |
| Free Cash Flow | $37,537 | $31,978 | $34,274 | $83,530 |

46

## Market risk

As filed, 5,351 characters.

In the normal course of business, we are exposed to interest rate and foreign currency exchange rate risks that could impact our financial position and results of operations. As part of our risk management strategy, we may use derivative financial instruments to hedge certain foreign currency and interest rate exposures. Our objective is to offset gains and losses resulting from these exposures with losses and gains on the derivative contracts used to hedge them, therefore reducing the impact of volatility on earnings or protecting the fair values of assets and liabilities. We use derivative contracts only to manage existing underlying exposures. Accordingly, we do not use derivative contracts for trading or speculative purposes.

#### Interest Rate Risk

We are exposed to interest rate risk through our variable rate debt instruments. In March 2020, we entered into an interest rate swap, which is effective from June 30, 2020 to June 30, 2023, and converts $240 million of our LIBOR-based debt from a floating LIBOR interest rate to a fixed interest rate of 0.617% (excluding the applicable margin). The notional balance will amortize to maturity at the same rate of originally required amortizations on our term loan. At September 30, 2020, our LIBOR-based debt balance was $950.2 million.

In April 2018, we entered into a cross-currency swap, which converts $56.0 million of floating rate LIBOR-based U.S. dollar denominated debt into 1.38% fixed rate euro denominated debt. This cross-currency swap matures on April 30, 2021 and mitigates the risk associated with fluctuations in interest and currency rates impacting cash flows related to a U.S. dollar denominated debt in a euro functional currency entity.

The table below provides information about our financial instruments that are sensitive to changes in interest rates and the scheduled minimum repayment of principal and the weighted average interest rates at September 30, 2020. Weighted average variable rates in the table are based on implied forward rates in the Reuters U.S. dollar yield curve as of September 30, 2020 and our estimated leverage ratio, which determines our additional interest rate margin at September 30, 2020.

*Dollars in thousands*

| Variable Rate Debt | 2020 | 2021 | 2022 | 2023 | 2024 | Total | Fair Value |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Principal: U.S. dollar term loan | $— | $32,422 | $44,063 | $44,063 | $429,608 | $550,156 | $533,223 |
| Weighted average interest rate | 1.65% | 1.64% | 1.65% | 1.72% | 1.87% |  |  |
| Principal: Multicurrency revolving line of credit | $— | $— | $— | $— | $400,000 | $400,000 | $386,086 |
| Weighted average interest rate | 1.65% | 1.64% | 1.65% | 1.72% | 1.87% |  |  |
| Interest rate swap |  |  |  |  |  |  |  |
| Weighted average interest rate (pay) Fixed | 0.62% | 0.62% | 0.62% | 0.62% |  |  |  |
| Weighted average interest rate (receive) Floating LIBOR | 0.15% | 0.14% | 0.15% | 0.19% |  |  |  |
| Cross currency swap |  |  |  |  |  |  |  |
| Weighted average interest rate (pay) Fixed - EURIBOR | 1.38% | 1.38% |  |  |  |  |  |
| Weighted average interest rate (receive) Floating - LIBOR | 0.15% | 0.17% |  |  |  |  |  |

Based on a sensitivity analysis as of September 30, 2020, we estimate that, if market interest rates average one percentage point higher in 2020 than in the table above, our financial results in 2020 would not be materially impacted.

We continually monitor and assess our interest rate risk and may institute additional interest rate swaps or other derivative instruments to manage such risk in the future.

#### Foreign Currency Exchange Rate Risk

We conduct business in a number of countries. Revenues denominated in functional currencies other than the U.S. dollar were 37% and 36% of total revenues for the three and nine months ended September 30, 2020 compared with 38% and 37% for the same respective periods in 2019. These transactions expose our account balances to movements in foreign currency exchange rates that could have a material effect on our financial results. Our primary foreign currency exposure relates to non-U.S. dollar denominated transactions in our international subsidiary operations, the most significant of which is the euro.

We are also exposed to foreign exchange risk when we enter into non-functional currency transactions, both intercompany and third party. At each period-end, non-functional currency monetary assets and liabilities are revalued with the change recognized to other income and expense. We enter into monthly foreign exchange forward contracts, which are not designated for hedge accounting, with the intent to reduce earnings volatility associated with currency exposures. As of September 30, 2020, a total of 43 contracts were offsetting our exposures from the euro, Canadian dollar, Pound Sterling, Brazilian Real, Chinese yuan and various other currencies, with notional amounts ranging from $102,000 to $26.4 million. Based on a sensitivity analysis as of September 30, 2020, we estimate that, if foreign currency exchange rates average ten percentage points higher in 2020 for these financial instruments, our financial results in 2020 would not be materially impacted.

In future periods, we may use additional derivative contracts to protect against foreign currency exchange rate risks.

## Controls and procedures

As filed, 1,695 characters.

#### Evaluation of disclosure controls and procedures

An evaluation was performed under the supervision and with the participation of our Company's management, including the Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of the Company's disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e)) under the Securities Exchange Act of 1934 as amended. Based on that evaluation, the Company's management, including the Chief Executive Officer and Chief Financial Officer, concluded that as of September 30, 2020, the Company's disclosure controls and procedures were effective to ensure the information required to be disclosed by an issuer in the reports that it files or submits under the Securities Exchange Act of 1934 is accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. There are inherent limitations to the effectiveness of any system of disclosure controls and procedures, including the possibility of human error and the circumvention or overriding of the controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide reasonable assurance of achieving their control objectives.

#### Changes in internal controls over financial reporting

There have been no changes in our internal control over financial reporting during the three months ended September 30, 2020 that materially affected, or are reasonably likely to materially affect, internal control over financial reporting.

## Risk factors

As filed, 4,777 characters.

For a complete list of Risk Factors, refer to Item 1A: "Risk Factors" of Part I of our Annual Report on Form 10-K for the fiscal year ended December 31, 2019, which was filed with the Securities and Exchange Commission on February 27, 2020.

*We have been and will continue to be affected by the ongoing COVID-19 pandemic, and such effects could have an adverse effect on our business operations, results of operations, cash flows, and financial condition.*

We have experienced disruptions to our business from the ongoing COVID-19 pandemic, and the full impact of the COVID-19 pandemic on all aspects of our business and geographic markets is highly uncertain and cannot be predicted with confidence. This includes how it may impact our customers, employees, vendors, strategic partners, managed services, and manufacturing operations. The COVID-19 pandemic has created significant volatility, uncertainty, and economic disruption, which has and may continue to materially and adversely affect our business operations, cash flows, and financial condition.

The impact of the virus on third parties on which we rely, such as our suppliers, contract manufacturers, distributors, and strategic partners, cannot be fully known or controlled by us. As a result, we may experience difficulties sourcing components and other critical inventory. The impact of the COVID-19 pandemic on our customers and demand for our products is also uncertain. Due to resulting financial constraints, illness within their organizations, quarantine and travel restrictions placed upon our customers’ employees, as well as individual actions our customers may take in response to the spread of COVID-19, our customers may have difficulty in making timely payments to us or may have an inability or unwillingness to purchase our products and services. Also, certain of our projects require regulatory approvals, and our customers may experience delays in regulatory approvals. Any of these effects may materially and adversely affect us.

Our management has taken measures, both voluntary and as a result of government directives and guidance, to mitigate the effects of the COVID-19 pandemic on us and others. These measures include, among others, restrictions on our employees' access to our physical work locations and the purchase of personal protective equipment. Additionally, we may implement the temporary closure or reduction in operations of certain of our manufacturing facilities, which would be disruptive to our operations. We have also implemented measures to allow certain employees to work remotely, which may place a burden on our IT systems and may expose us to increased vulnerability to cyber-attack and other cyber-disruption. Many of these measures may result in incremental costs to us, and such costs may not be recoverable or adequately covered by our insurance. Further, any focus by our management on mitigating COVID-19 effects has required, and will continue to require, a large investment of time and resources, which may delay other value-add initiatives.

As a company with global operations, we are subject to numerous government jurisdictions at all levels that are addressing COVID-19 differently. The guidance and directives provided by these governmental authorities is difficult to predict, may be unclear in their application, and are unknown in duration. This includes uncertainty in governmental authorities’ assessments of our business as “essential”. If governmental authorities were to reverse their designation of our business as “essential”, it could have a material effect on our results of operations and cash flows.

The full extent to which the COVID-19 pandemic impacts us depends on numerous evolving factors and future developments that we are not able to predict at this time, including: medical advancements to treat or stop the virus; governmental, business, and other actions (which could include limitations on our operations to provide products or services); the duration of the outbreak and the related limitations on our ability to conduct business; or the length of time and velocity at which we will return to more normalized operations. In addition, we cannot predict the impact that COVID-19 will have on our customers, vendors, strategic partners, and other business partners and each of their financial conditions; however, any material effect on these parties could materially and adversely impact us. The impact of COVID-19 may also include possible impairment or other charges and may exacerbate other risks discussed in Item 1A: Risk Factors in our Annual Report on Form 10-K, any of which could have a material effect on us. This situation is changing rapidly and additional impacts may arise that we are not aware of currently.

Filed Nov 2, 2020.
Source: SEC EDGAR, the filing index for accession 0000780571-20-000025. Last ingested by Listed: Nov 4, 2026, 12:46 ET. No prices; not investment advice.
